What Is an Adenoma? Causes, Symptoms, and Treatment

An adenoma is a benign tumor that grows from glandular tissue, the type of tissue that lines organs and produces secretions like hormones, mucus, or digestive fluids. Adenomas can appear in the colon, pituitary gland, thyroid, adrenal glands, liver, and parathyroid glands, among other sites. Most are harmless and never cause symptoms, but some produce excess hormones, press on nearby structures, or carry a real risk of turning cancerous over time. Whether an adenoma matters depends almost entirely on where it is, how big it gets, and what it is doing.

Where Adenomas Grow and Why Location Matters

Glandular tissue is everywhere in the body, so adenomas can show up in many places. The most commonly discussed types are colorectal adenomas (polyps found during colonoscopy), pituitary adenomas (small tumors in the hormone-regulating gland at the base of the brain), adrenal adenomas (usually found incidentally on abdominal imaging), thyroid adenomas (nodules in the thyroid gland), hepatic adenomas (liver tumors linked to hormonal contraceptives), and parathyroid adenomas (which drive excess calcium production). Each behaves differently, causes different symptoms, and calls for different management.

The reason location matters so much is that an adenoma’s clinical significance comes from context. A tiny adenoma in the colon may be snipped out during a routine screening colonoscopy and forgotten. A similarly small adenoma in the pituitary gland might flood the body with prolactin or growth hormone, causing symptoms that seem to have nothing to do with a brain tumor. Understanding what an adenoma is doing, or could do, requires knowing where it sits.

Colorectal Adenomas and the Path Toward Cancer

Colorectal adenomas are by far the most familiar type, because screening colonoscopy was designed to find and remove them before they become cancerous. Not all colon polyps are adenomas, but adenomas are the ones that carry malignant potential. The progression from a normal cell to an adenoma and eventually to colorectal cancer is driven by an accumulation of mutations in specific genes, with changes in the APC, KRAS, and TP53 genes playing central roles at successive stages of that transition.1Proceedings of the National Academy of Sciences. Driver mutations of the adenoma-carcinoma sequence govern the intestinal epithelial global translational capacity Research comparing the frequency of these mutations in adenomas versus early carcinomas has found that TP53 mutations, for example, appear more often as lesions become more advanced, suggesting they come into play later in the sequence.2Scientific Reports. Mutational analysis of driver genes defines the colorectal adenoma: in situ carcinoma transition

Colorectal adenomas come in several subtypes. Tubular adenomas are the most common and generally the least worrisome. Tubulovillous and villous adenomas carry higher risk. A large prospective study found that people with tubulovillous or villous adenomas were about fifty percent more likely to develop colorectal cancer compared to those with tubular adenomas.3PubMed Central. Colorectal cancer risk following adenoma removal: a large prospective population-based cohort study When these adenomas do progress to cancer, the subtype continues to matter. An analysis of registry data found that cancers arising from villous adenomas had worse survival than those arising from tubular adenomas.4PubMed. Cancer-specific survival of colorectal adenocarcinomas according to the type of pre-existing adenoma

Size and degree of abnormality also matter. Adenomas 20 mm or larger, those with villous features, and those showing high-grade dysplasia all carry elevated risk for future colorectal cancer even after removal. A meta-analysis found that high-grade dysplasia nearly tripled the risk of later cancer compared to low-grade changes, and adenomas 20 mm and above roughly doubled that risk compared to those in the 10-to-19-mm range.5PubMed. Risk Factors for Metachronous Colorectal Cancer or Advanced Adenomas After Endoscopic Resection of High-risk Adenomas

Pituitary Adenomas

Pituitary adenomas are surprisingly common, often showing up incidentally on brain imaging done for unrelated reasons. About thirty percent of them are nonfunctioning, meaning they do not secrete excess hormones. The rest are “functioning” tumors that pump out one or more hormones, and the symptoms depend on which hormone is overproduced. Roughly half of all pituitary adenomas are prolactinomas, which secrete prolactin and can cause menstrual irregularities, infertility, or unexpected breast milk production. About twelve percent produce growth hormone, leading to acromegaly in adults, and around four percent secrete corticotropin, causing Cushing disease with its characteristic weight gain, thin skin, and high blood sugar.6JAMA. Diagnosis and Management of Pituitary Adenomas: A Review

Larger pituitary adenomas, called macroadenomas, can also cause problems by pressing on surrounding structures. Visual field defects, headaches, and loss of normal pituitary function are all reported, sometimes affecting the majority of patients with macroadenomas depending on tumor size and direction of growth.6JAMA. Diagnosis and Management of Pituitary Adenomas: A Review This is a case where an entirely benign tumor can cause serious harm just from its location.

Adrenal, Thyroid, Parathyroid, and Liver Adenomas

Adrenal adenomas are commonly found by accident when someone gets a CT scan or MRI for an unrelated problem. The rate of these “incidentalomas” has risen dramatically with modern imaging. Most are benign and do nothing, but doctors still need to determine two things: whether the mass is malignant and whether it is producing excess hormones. Malignancy is found in roughly five to eight percent of adrenal tumors, and mild autonomous cortisol secretion shows up in as many as thirty to fifty percent of cases, which can contribute to metabolic problems over time.7PubMed Central. Approach to the Patient With Adrenal Incidentaloma

Thyroid adenomas present as nodules. A minority of these are “hot” nodules that take up more radioactive iodine than surrounding tissue, sometimes producing excess thyroid hormone. In one study of such nodules, most turned out to be benign follicular adenomas, though a small number were cancerous.8American Journal of Clinical Pathology. Autonomously Functioning (Hot) Nodule of the Thyroid Gland: A Clinical and Histopathologic Study of 17 Cases Most thyroid adenomas, however, are nonfunctioning and found during imaging or physical examination.

Parathyroid adenomas are the cause behind most cases of primary hyperparathyroidism, accounting for eighty to eighty-five percent of them.9PubMed Central. Primary hyperparathyroidism-related giant parathyroid adenoma They are typically small, but by secreting excess parathyroid hormone, they raise blood calcium levels, which over time can weaken bones, cause kidney stones, and produce vague but persistent fatigue and cognitive fog. The condition is most common in postmenopausal women.10JCEM Case Reports. Ectopic parathyroid adenoma with severe osteoporosis in premenopausal woman

Hepatic adenomas, or hepatocellular adenomas, are uncommon liver tumors strongly linked to oral contraceptive use. A landmark study found that women with these tumors had used oral contraceptives for significantly longer than matched controls, and mestranol-containing pills were used far more frequently among cases.11PubMed. Liver-cell adenomas associated with use of oral contraceptives The main concerns with hepatic adenomas are bleeding, which occurs in roughly fifteen to twenty percent, and malignant transformation to liver cancer, which occurs in about five percent.12PubMed Central. The effect of oral contraceptive pill cessation on hepatocellular adenoma diameter: A retrospective cohort study Larger tumors, those protruding from the liver surface, and those with visible arterial blood supply on imaging are at the highest risk for hemorrhage.13BJS. Risk factors for bleeding in hepatocellular adenoma Molecular classification of hepatic adenomas into subtypes has been an important advance, because different subtypes carry different risks of turning malignant.14PubMed. Hepatocellular adenoma: Classification, variants and clinical relevance

Causes and Modifiable Risk Factors

For most adenomas, there is no single cause. The mutations that give rise to them accumulate over a lifetime, which is why age is the strongest non-modifiable risk factor for colorectal adenomas. Hereditary conditions can accelerate the process. Familial adenomatous polyposis, for instance, involves a germline mutation in the APC gene that leads to hundreds or thousands of colorectal adenomas at a young age. For pituitary adenomas, several inherited syndromes have been identified, including Multiple Endocrine Neoplasia type 1 (MEN1), Carney complex, and Familial Isolated Pituitary Adenoma syndrome, each involving distinct gene defects.15PubMed Central. The Genetics of Pituitary Adenomas These syndromes are rare, but they matter in families where adenomas appear at unusually young ages or in multiple family members.

For colorectal adenomas in particular, several lifestyle factors shift your risk. Obesity and current smoking are both associated with higher odds of developing conventional adenomas and advanced lesions.16Scientific Reports. Different modifiable risk factors for the development of non-advanced adenoma, advanced adenomatous lesion, and sessile serrated lesions, on screening colonoscopy High red meat intake has been linked to an elevated risk of sessile serrated polyps, a distinct polyp pathway. Regular use of anti-inflammatory drugs like aspirin or ibuprofen has been associated with roughly a forty percent reduction in sessile serrated polyp risk.17Gut. Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps These findings do not mean you should start taking aspirin to prevent polyps without talking to a doctor, since the bleeding risks of regular aspirin use are real. But they do illustrate that colorectal adenoma formation is not purely a matter of bad luck.

How Adenomas Are Found

The method of discovery varies by location. Colorectal adenomas are usually found during screening colonoscopy. Pituitary adenomas often show up on MRI scans. Adrenal adenomas are frequently discovered incidentally on abdominal CT scans done for other reasons.7PubMed Central. Approach to the Patient With Adrenal Incidentaloma Thyroid adenomas may be felt during a physical exam or seen on an ultrasound. Parathyroid adenomas are usually suspected based on blood test abnormalities, specifically elevated calcium and parathyroid hormone, and then localized with imaging.

For colorectal adenomas, the quality of the colonoscopy matters. Advanced imaging techniques such as narrow-band imaging and autofluorescence imaging can improve the ability to tell an adenoma from a harmless hyperplastic polyp. In one study, combining these modalities boosted diagnostic accuracy above ninety percent and dramatically improved the performance of less experienced physicians.18PubMed. The diagnostic accuracy of high-resolution endoscopy, autofluorescence imaging and narrow-band imaging for differentially diagnosing colon adenoma The emergence of real-time artificial intelligence systems has pushed detection further. A pooled analysis of trials comparing AI-assisted colonoscopy to standard colonoscopy found that AI support increased the odds of detecting polyps by about thirty percent.19PubMed Central. Real-Time Artificial Intelligence Versus Standard Colonoscopy in the Early Detection of Colorectal Cancer: A Systematic Review and Meta-Analysis A prospective trial found that AI raised the adenoma detection rate from about twenty percent to twenty-nine percent, largely by catching more small adenomas that human eyes might miss.20Gut. Real-time automatic detection system increases colonoscopic polyp and adenoma detection rates: a prospective randomised controlled study

Treatment Approaches

Treatment depends entirely on the type of adenoma and what it is doing. Most colorectal adenomas are simply removed during the colonoscopy itself, a procedure called polypectomy. Larger or more complex polyps may require specialized endoscopic techniques. Once the adenoma is out and sent to the lab, the pathologist’s report determines the next steps, whether you need closer follow-up or can wait longer before the next scope.

Pituitary adenomas have a wider range of treatment options. Prolactinomas, which make up the majority, are unusual among tumors in that medication rather than surgery is the standard first-line treatment. Dopamine agonist drugs shrink most prolactinomas and normalize hormone levels effectively.21PubMed Central. Dopamine Agonists for Pituitary Adenomas These medications also show some benefit in other pituitary tumor types, shrinking nonfunctioning tumors in about thirty percent of patients and stabilizing them in roughly sixty percent.21PubMed Central. Dopamine Agonists for Pituitary Adenomas For acromegaly, dopamine agonists normalize growth factor levels in about a third of patients and are sometimes combined with other drugs for better results.22British Journal of Clinical Pharmacology. Dopamine agonists for the treatment of pituitary tumours: From ergot extracts to next generation therapies When surgery is needed, endoscopic transsphenoidal surgery, performed through the nose, has become the standard approach and has improved over time with better tools and techniques.23PubMed Central. Evolution of Technique in Endoscopic Transsphenoidal Surgery for Pituitary Adenoma There is ongoing debate about whether surgery should be offered earlier for prolactinomas rather than committing patients to years of medication, particularly since dopamine agonists can cause side effects like nausea, fatigue, and occasionally compulsive behaviors.24PubMed Central. Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?

For adrenal adenomas, management hinges on whether the tumor is producing hormones and whether there is concern about malignancy. Many are simply monitored with repeat imaging. Parathyroid adenomas that cause hyperparathyroidism are treated surgically, and the surgery is often curative. Hepatic adenomas may shrink if oral contraceptives are stopped; larger ones, especially those over 50 mm or with high-risk molecular subtypes, may be resected to prevent bleeding or malignant change.

Surveillance After Colorectal Adenoma Removal

Removing a colorectal adenoma is not the end of the story. Because the conditions that produced one adenoma can produce another, follow-up colonoscopy is standard practice. The timing depends on what was found and removed. Guidelines recommend the following intervals for repeat colonoscopy after a high-quality initial exam:

  • Low-risk findings: One or two small tubular adenomas under 10 mm warrant a repeat colonoscopy in seven to ten years.
  • Moderate findings: Three to four small tubular adenomas call for a repeat in three to five years.
  • Higher-risk features: Any adenoma 10 mm or larger, adenomas with villous features, or those with high-grade dysplasia mean a repeat in three years.
  • Heavy adenoma burden: More than ten adenomas should prompt a repeat at one year.25Gastroenterology. Follow-up after colonoscopy and polypectomy

A reasonable question is whether these surveillance intervals genuinely need to be as short as they are, given the cost and discomfort of colonoscopy. A large trial recently addressed this by comparing less-frequent with more-frequent surveillance. The five-year colorectal cancer rate was essentially the same in both groups, just under one percent, meeting the statistical threshold for non-inferiority of the less-frequent approach.26PubMed. Colonoscopy Intervals and Colorectal Cancer Incidence after Adenoma Removal A separate retrospective study found that surveillance was most cost-effective for the highest-risk patients, while people with low-risk adenomas had cancer rates no higher than the general population even without surveillance.27PubMed Central. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study This is a space where guidelines may continue to evolve as more evidence accumulates. For now, if your adenoma was small, few in number, and had no worrisome features on pathology, you can feel reassured that the interval before your next colonoscopy is appropriately long.

Adenomas in Animals

Adenomas are not unique to humans. Veterinary pathologists find pituitary adenomas in dogs and cats, among other species. One study examining pituitary glands from dogs and cats found pituitary tumors in over fourteen percent of middle-aged and older dogs, many of them producing adrenocorticotropic hormone, the same hormone that drives Cushing disease in people.28PubMed. Pathological Findings in the Pituitary Glands of Dogs and Cats Cushing syndrome is in fact one of the most common hormonal disorders in older dogs, and the underlying cause is often a pituitary adenoma. Cats appear less affected but can develop similar lesions. The shared biology across species reflects the fundamental nature of adenomas: anywhere glandular tissue exists and cells divide, an adenoma can form. The mechanisms are conserved across mammals, which is also why animal models continue to inform research on how these tumors arise and progress in humans.